1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 26382777 | Re: Phase III, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) plus Prednisone with Placebo plus Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer that has Progressed during or after Docetaxel-Based Therapy: ELM-PC 5. | 2015 Oct | 1 |